From the Bunker: The "Other" Asset Classes
Evan and Tom look at the most commonly asked about assets when it comes to investing.
Early super withdrawal... is it taxed? A house in the city, a place in the country...can it be done?
Top financial adviser Sally Huynh joins James Kirby in this week's episode of The Money Café for a discussion on the key issues and investment trends emerging from COVID including gold's spectacular rally, early super withdrawals and the state of industry funds as airports and toll roads struggle.
Australian property market's great escape
Alex Gluyas speaks with the CEO of REA Group, Owen Wilson, about the year that has been in Australia's property market, from the Hayne Royal Commission's impact, the signs of recovery earlier this year and then the onset of COVID, and his thoughts on why the property market might escape in better condition than first thought.
Earnings season tracking better than expected
This week on Talking Finance, Alex Gluyas is joined by Professor of Infectious Diseases at ANU’s Medical School, Professor Peter Collignon, for a global discussion on all things COVID, including how safe Russia's rushed vaccine is, Sweden's herd immunity strategy and why Australia needs to learn how to live with the virus, while Portfolio Manager at Tribeca Investment Partners, Jun Bei Liu, gives her take on earnings season so far and what's driven the Nasdaq and S&P 500 to record highs. EY Oceania Chief Economist, Jo Masters, explains why Australia's economic fundamentals place it in better shape than most nations to get through the current downturn and Political Editor at The New Daily, Josh Butler, shares his thoughts on Victoria's hotel quarantine inquiry and China’s latest curveball to Australia’s wine industry.
4DMedical: Taking lung imaging to the next level
Following its recent listing on the ASX, Alex Gluyas speaks with the founder and CEO of 4DMedical, Andreas Fouras, to discuss the company's lung imaging technology, its usefulness in detecting and managing acute respiratory distress syndrome (ARDS) in COVID patients and the process of commercialising in the US and beyond.
Ava Risk Group results 'nothing but positive'
Alex Gluyas catches up with the CEO of Ava Risk Group, Rob Broomfield, to discuss his transition to being the group's CEO, how the company has navigated through COVID and its most recent quarterly update which saw its share price spike.
SMSF Q&A: 13 August 2020
In this week's Q&A, Eureka Report's SMSF Coach and Prime Financial Group's Managing Director of SMSF, Olivia Long, answers a number of subscriber questions relating to self-managed super funds.
How Zoom adapted as the world rushed online
With the onset of COVID, Zoom's daily active participants soared from 10 million to 300 million. Alex Gluyas catches up with the video conferencing giant's head of Australia and Asia Pacific, Michael Chetner, to discuss how it was forced to pivot from focusing on its main enterprise market to keeping society connected, the privacy and security issues it's faced and where Zoom fits into life post-COVID.
Kiwi biotech makes its mark in ASX debut
Following its recent listing on the ASX, Alex Gluyas speaks with the CEO of Aroa Biosurgery, Brian Ward, to discuss the company's IPO, its medical products used for soft tissue regeneration, and the expansion of its commercial operations in the US and beyond.
QVG Capital's long-short strategy proves a winner
After its Long Short fund was named by Mercer as the top-performing fund investing in Australian shares for FY20, Alex Gluyas speaks with Principal and Portfolio Manager at QVG Capital, Tony Waters, to discuss how QVG is navigating through COVID-19, the best picks that contributed to its performance, and the filters it uses when picking stocks to long or short.
Remote work boom drives LiveTiles to cash flow positive quarter
Alex Gluyas catches up with the CEO of LiveTiles, Karl Redenbach, to discuss the increased demand for its workplace collaboration technology, how this contributed to the company achieving a cash flow positive June quarter, and its focus on product innovation through artificial intelligence.
Is investing in gold ridiculous?
James Kirby is joined by financial adviser Doug Turek in this week's episode of The Money Cafe for a distanced chat about how he is managing portfolios in 2020, and the haunting sense hanging over markets.